Ocuphire Pharma Inc (NASDAQ:OCUP)
| 2.97 Delayed Data As of Dec 01 |  -0.08 / -2.62%Today’s Change | 2.48 Today|||52-Week Range 6.60 | -15.86% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 27.5K | 32.9K | 42.4K | 48.2K | ||
| Operating Expenses | Gross Income | -27.5K | -32.9K | -42.4K | -48.2K | |
| General Expenses | 18.2M | 16.4M | 17.3M | 20.5M | ||
| Research And Development | 12.1M | 10.1M | 10.7M | 13.1M | ||
| Total Operating Expenses | 18.3M | 16.4M | 17.4M | 20.5M | ||
| Non-Operating Expenses | Operating Income | -18.3M | -16.4M | -17.4M | -20.5M | |
| Extraordinary Credit | 4.0M | 7.3M | 0.00 | 5.5M | ||
| Extraordinary Charge | 0.00 | 0.00 | -7.6M | 0.00 | ||
| Interest Expense On Debt | 0.00 | 313.1K | 0.00 | 0.00 | ||
| Other Expenses | -211.1K | 0.00 | -552.6K | 368.8K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -14.4M | -9.3M | -25.3M | -14.4M | |
| Net Income | -14.4M | -9.3M | -25.3M | -14.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.5M | 1.8M | 2.3M | 2.7M | |
| Shares To Calculate EPS Diluted | 1.5M | 1.8M | 2.3M | 2.7M | ||
| Earnings Per Share | EPS | -$9.60 | -$4.80 | -$11.04 | -$5.28 | |
| EPS Diluted | -$9.60 | -$4.80 | -$11.04 | -$5.24 | ||
